Treatment with biologics during pregnancy in patients with rheumatic diseases
- PMID: 28539675
- PMCID: PMC5442294
- DOI: 10.5114/reum.2017.67598
Treatment with biologics during pregnancy in patients with rheumatic diseases
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis. 2015;74:1836–1841. - PubMed
-
- Ostensen M, Villiger PM, Forger F. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev. 2012;11:A437–446. - PubMed
-
- Gotestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810. - PubMed
-
- Komaki F, Komaki Y, Micic D, et al. Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-alpha use in females with immune mediated diseases; a systematic review and meta-analysis. J Autoimmun. 2017;76:38–52. - PubMed
-
- Forger F, Villiger PM. Treatment of rheumatoid arthritis during pregnancy: present and future. Exp Rev Clin Immunol. 2016;12:937–944. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources